High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer

Biomark Med. 2024;18(10-12):523-533. doi: 10.1080/17520363.2024.2347192. Epub 2024 May 24.

Abstract

Aim: To evaluate correlations of tumor PLK3 with clinical features and prognosis of resectable endometrial cancer (EC) patients.Methods: Tumor tissues from 200 EC patients receiving surgical resections and adjacent tissues from 50 of them were collected for PLK3 determination using immunohistochemistry.Results: Tumor PLK3 negatively linked with myometrial invasion ≥50%, lymphovascular invasion, stromal cervical invasion, and International Federation of Gynecology and Obstetrics stage (all p < 0.050). High tumor PLK3 independently related to longer disease-free survival (DFS) (p = 0.044) and overall survival (OS) (p = 0.049). Its prognostic value was also validated by time-dependent receiver operating characteristic analyses (area under curve at most timepoints was >0.700).Conclusion: Tumor PLK3 potentially reflects prolonged DFS and OS in EC patients undergoing surgical resections.

Keywords: clinical features; disease-free survival; endometrial cancer; overall survival; polo-like kinase 3.

Plain language summary

[Box: see text].

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / metabolism
  • Disease-Free Survival
  • Endometrial Neoplasms* / diagnosis
  • Endometrial Neoplasms* / metabolism
  • Endometrial Neoplasms* / mortality
  • Endometrial Neoplasms* / pathology
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness*
  • Neoplasm Staging*
  • Polo-like Kinases
  • Prognosis
  • Protein Serine-Threonine Kinases* / genetics
  • Protein Serine-Threonine Kinases* / metabolism
  • ROC Curve
  • Tumor Suppressor Proteins

Substances

  • Protein Serine-Threonine Kinases
  • PLK3 protein, human
  • Biomarkers, Tumor
  • Polo-like Kinases
  • Tumor Suppressor Proteins